TODAY! Year End 2016 Financial Results - Lattice Biologics Financial results to be released after market on Monday, January 30, 2017
SCOTTSDALE, AZ--(Marketwired - January 27, 2017) - Lattice Biologics Ltd. (TSX VENTURE: LBL) (OTCBB: LBLTF) (the "Company") announced today that it will release its year ended September 30, 2016 financial results after market on Monday, January 30, 2017. Following this, Guy Cook, Chief Executive Officer, and Cheryl Farmer, Chief Financial Officer, will host a conference call at 6:30 a.m. PDT on Tuesday, January 31, 2017 to review the results. A question and answer session will follow the corporate update.
| | | |
| CONFERENCE CALL DETAILS: | | |
| DATE: | | Tuesday, January 31, 2017 |
| TIME: | | 6:30 AM Pacific Time |
| DIAL-IN NUMBER: | | (213) 416-1560 |
| ATTENDEE PIN: | | 286 6963# |
| | | |
Register for the online webinar for full meeting functionality:
https://www.anymeeting.com/PIID=EC59DE8987493B
A recording of the call will be archived on the Company's website at:
https://www.latticebiologics.com/webinars/
Lattice Biologics Ltd.
Guy Cook,
Chief Executive Officer
Telephone No: (480) 563-0800
About Lattice Biologics Ltd.:
Lattice Biologics Ltd. is an emerging precision medicine leader in the field of cellular therapies and tissue engineering, with an emphasis on bone, skin, and cartilage regeneration. As a manufacturer of the highest quality allografts, Lattice is focused on next generation products to improve surgical outcomes.